Episode description
📢 Hear Jaishankar Kutty, Ph.D.'s four-minute summary on MDCG 2023-7 and how you can benefit from attending next week's RQM+ Live! panel discussion: New Clinical Evidence Pathways for Legacy and New Devices.
🎟️ RSVP for the 22 February event here.
Why are we talking about this?
To address and clarify potential misinterpretations of Article 61, Items 4, 5, and 6, highlighted by the formation of an MDCG task force.
End goal of next week's panel?
To answer audience questions and provide a robust discussion that leads to a renewed understanding of equivalence in the EU for everyone who attends.
🔗 RSVP and we'll email connection details. We'll be sharing exclusive content with those who sign up.
-
🎟️ RSVP for the 22 Feb. panel and get exclusive content.
📹 View and share this clip on LinkedIn.
📲 Follow RQM+ on LinkedIn.
📚 See on-demand content in our Knowledge Center.
📝 If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use our contact form.